On Sept. 16, the Centers for Medicare & Medicaid Services (CMS) announced the following Merit-based Incentive Payment System (MIPS) Value Pathways (MVPs) updates. An MVP is a reporting option that allows clinicians t...

Season 8 | Episode 17 In this episode of Talking Sleep, host Dr. Seema Khosla welcomes three patient advocates who are reshaping how sleep medicine is practiced and funded. Matt Horsnell, living with two sleep disorders...

A strategic integration between a teledentistry platform and a dental sleep laboratory aims to connect sleep apnea workflows with specialized oral appliance manufacturing.

A new survey reveals how diagnostic delays, mental health misdiagnoses, and inadequate treatments take a heavy toll on patients' daily lives and overall well-being.

A real-world study finds sustained use of tirzepatide in adults over 55 with obesity reduced costs, driven by fewer hospitalizations and emergency visits.

The AASM Case Study of the Month for September is live! Sleepwalking or something more?  A seven-year-old girl presents with recurrent sleepwalking and sleep talking several nights each week. Are these common childhood b...

Clinical and real-world analyses presented at SLEEP 2026 demonstrate that Xywav can be customized into regimens to optimize individual patient care in narcolepsy and idiopathic hypersomnia.

The registration supports the commercialization of SOMNUM Clinical, an AI-powered service designed to automate polysomnography data analysis for global research programs.

The Alkermes Pathways Research Awards program is now accepting applications for its ninth annual cycle, expanding its neuroscience grant offerings to include narcolepsy and idiopathic hypersomnia. Early-career investigat...

Results from two clinical trials show the medication improved measures of wakefulness, sleepiness, and cataplexy over a 12-week period.